Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial 18F-FDG PET/CT

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1306-1311

  Choi, Jin Woong ^a   Yoon, Young Hoon ^a   Yoon, Yeo Hoon ^a   Kim, Seong Min ^a   Koo, Bon Seok ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SIZE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; GENDER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; RETROSPECTIVE STUDY; THYROID PAPILLARY CARCINOMA; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79955831502     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1469-2     Document Type: Article

References (19)

1. L Pace E Nicolai M Klain, et al. 2009 Diagnostic value of FDG PET/CT imaging Q J Nucl Med Mol Imaging 53 5 503 512 19910903 1:STN:280: DC%2BD1MjlvFynsg%3D%3D
2. G Antoch N Saoudi H Kuehl, et al. 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 21 4357 4368 15514377 10.1200/JCO.2004.08.120 (Pubitemid 41185156)
3. R Bar-Shalom N Yefremov L Guralnik, et al. 2003 Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 8 1200 1209 12902408 (Pubitemid 39655178)
4. F Bertagna G Bosio G Biasiotto, et al. 2009 F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level Clin Nucl Med 34 11 756 761 19851169 10.1097/RLU.0b013e3181b7d95c
5. J Chung Y So J Lee, et al. 1999 Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan J Nucl Med 40 6 986 10452315 1:STN:280:DyaK1MznvFertg%3D%3D
6. A Razfar BFt Branstetter A Christopoulos, et al. 2010 Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma Arch Otolaryngol Head Neck Surg 136 2 120 125 20157055 10.1001/archoto.2009.215
7. MD Zuijdwijk WV Vogel FH Corstens, et al. 2008 Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma Nucl Med Commun 29 7 636 641 18528186 10.1097/MNM.0b013e3282f813e1 1:CAS:528:DC%2BD1cXms1yjtrs%3D
8. HS Jeong M Chung CH Baek, et al. 2006 Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas? Laryngoscope 116 12 2133 2137 17146385 10.1097/01.mlg.0000243043.65560.3f (Pubitemid 44912307)
9. JC Mitchell F Grant AR Evenson, et al. 2005 Preoperative evaluation of thyroid nodules with 18FDG-PET/CT Surgery 138 6 1166 1174 16360405 10.1016/j.surg.2005.08.031 discussion 1174-5 (Pubitemid 41797359)
10. M Luster W Karges K Zeich, et al. 2010 Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma Thyroid 20 5 527 533 20450432 10.1089/thy.2009.0342 1:CAS:528:DC%2BC3cXlvVOgsbY%3D
11. D Esteva MA Muros JM Llamas-Elvira, et al. 2009 Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer Ann Surg Oncol 16 7 2006 2013 19415387 10.1245/s10434-009-0483-8 1:STN:280:DC%2BD1Mvhs1Omtw%3D%3D
12. DS Cooper GM Doherty BR Haugen, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 11 1167 1214 19860577 10.1089/thy.2009.0110
13. NCCN. NCCN Clinical Practive Guidelines in Oncology: thyroid carcinoma Available: http://www.nccn.org/professionals/physician-gls/PDF/thyroid.pdf. Accessed 14 Oct 2010.
14. H Gharib E Papini R Paschke, et al. 2010 American association of clinical endocrinologists, Associazione Medici Endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations Endocr Pract 16 3 468 475 20551008
15. F Giammarile Z Hafdi C Bournaud, et al. 2003 Is [18F]-2-fluoro-2-deoxy-d- glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? Eur J Endocrinol 149 4 293 300 14514343 10.1530/eje.0.1490293 1:CAS:528:DC%2BD3sXoslKhtrk%3D (Pubitemid 37304699)
16. C Menzel K Zaplatnikov M Diehl, et al. 2004 The influence of thyroglobulin on functional imaging in differentiated thyroid cancer Nucl Med Commun 25 3 239 243 15094441 10.1097/00006231-200403000-00005 1:CAS:528:DC%2BD2cXnt1Ois7s%3D (Pubitemid 38393514)
17. B Schluter KH Bohuslavizki W Beyer, et al. 2001 Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan J Nucl Med 42 1 71 76 11197983 1:STN:280:DC%2BD3M7isVyltw%3D%3D (Pubitemid 32104780)
18. E Puxeddu S Filetti 2009 The 2009 American thyroid association guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus-to evidence-based practice Thyroid 19 11 1145 1147 19888856 10.1089/thy.2009.1601
19. RM Tuttle R Leboeuf AJ Martorella 2007 Papillary thyroid cancer: monitoring and therapy Endocrinol Metab Clin North Am 36 3 753 778 17673127 10.1016/j.ecl.2007.04.004 1:CAS:528:DC%2BD2sXhtFCgsrjN vii (Pubitemid 47135588)